再发传染病-猴痘研究进展  

Research progress of the re-emerging monkeypox epidemic

作　　者：彭嘉怡 代海峰 王丹妮[2] 童可欣 陈明镜 张佳 陈宣辛 黄文祥[1] Peng Jiayi;Dai Haifeng;Wang Danni;Tong Kexin;Chen Mingjing;Zhang Jia;Chen Xuanxin;Huang Wenxiang(Department of Geriatrics,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China;Department of Infectious Diseases,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)

机构地区：[1]重庆医科大学附属第一医院老年病科,400016 [2]重庆医科大学附属第一医院感染科,400016

出　　处：《中华临床感染病杂志》2023年第1期67-74,共8页Chinese Journal of Clinical Infectious Diseases

摘　　要：自2022年5月起猴痘首次在全球非流行地区出现暴发流行,被世界卫生组织定义为国际关注的突发公共卫生事件。本次猴痘疫情与以往非洲地区流行的猴痘疫情相比,在病原学、流行病学及临床特点等方面均表现出较大差异。本文就此次猴痘疫情病毒的病原学、流行病学、临床表现以及目前可及的抗病毒治疗、疫苗进行综述,为猴痘临床防治提供参考。The first global outbreak of monkeypox in non-epidemic regions occurred in May 2022,and the World Health Organization defined it as a public health emergency of international concern in July 2022.Compared with previous outbreaks of monkeypox in Africa,the current one is different in etiology,epidemiology and clinical characteristics.This article reviews the features of the latest outbreak of monkeypox,and the currently available antiviral treatment and vaccines,so as to provide reference for the prevention and treatment of monkeypox.

关 键 词：猴痘 流行病学 临床表现 抗病毒治疗 疫苗 

分 类 号：R511[医药卫生—内科学]